Norgine and European Liver Patients Association (ELPA) Continuing to Improve the Management of Hepatic Encephalopathy

LONDON, April 19, 2017 /PRNewswire/ --

-Launching new hepatic encephalopathy patient leaflet in 11 languages 

-Launching new patient passport to help manage disease and interactions with care team 

Norgine and ELPA today launched a patient leaflet to improve the early detection of hepatic encephalopathy, and a patient passport to facilitate conversations with healthcare professionals. Hepatic encephalopathy remains under-diagnosed and under-treated, as many patients and carers are unaware of the signs and symptoms of the disease. In addition, healthcare providers don't always identify and treat the often subtle symptoms of hepatic encephalopathy, and this can lead to poor patient outcomes and increased hospital admissions.^[1]

To view the Multimedia News Release, please click:

https://www.multivu.com/players/uk/8086251-norgine-elpa-hepatic-encephalopathy/

Hepatic encephalopathy is a significant complication of advanced chronic liver disease, and occurs in up to 40% of patients or as many as 200,000* people in Europe.^[1],[2]

Tatjana Reic, President, ELPA said "In Europe, 200,000 people are affected by hepatic encephalopathy, yet despite the severity of the disease it is still under-diagnosed and under-treated. The new patient leaflet and passport are welcome as they will help patients and their carers to manage this debilitating disease which can significantly impact people's lives and those who care for them."

Peter Martin, Chief Operating Officer, Norgine said "Norgine is highly committed to working with ELPA so together we can ensure that hepatic encephalopathy is recognised as a life threatening condition and that patients can be managed accordingly."

Click here to download Understanding Hepatic Encephalopathy patient leaflet

Click here to download Patient Passport

Understanding Hepatic Encephalopathy patient leaflet, patient passport and Time to DeLiver report are sponsored by Norgine.

View the full press release on http://www.norgine.com

Ends 

*Assumes European population is 500,000

1. Hepatic Encephalopathy in Chronic Liver Disease: 2014 Practice Guideline by the European Association for the Study of the Liver and the American Association for the Study of Liver Diseases. Journal of Hepatology 2014; 61(3):642-659 

2. Mullen KD. Review of the final report of the 1998 Working Party on definition, nomenclature and diagnosis of hepatic encephalopathy. Aliment Pharmacol Ther. 2007 Feb;25 Suppl 1:11-6. 

ELPA media contacts
Livia Alimena, Public Affairs Director
pad@elpa-info.org

Norgine media contacts
Isabelle Jouin, T: +44-(0)1895-453643
Charlotte Andrews, T: +44-(0)1895-453607
Follow us @Norgine 

     (Logo: http://photos.prnewswire.com/prnh/20130829/633895-a )

     (Logo: http://mma.prnewswire.com/media/491111/ELPA_Logo.jpg )

Video: 
     https://www.multivu.com/players/uk/8086251-norgine-elpa-hepatic-encephalopathy/

SOURCE Norgine and ELPA